Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

Rising IP Star Advocate Urvashi M. Dooshi Named 'Woman Leader To Look Up To In 2024'

Rising IP Star Advocate Urvashi M. Dooshi Named 'Woman Leader To Look Up To In 2024'

Top 10 Share Market Training Institutes In India In 2024

Top 10 Share Market Training Institutes In India In 2024

How This Consultant Built A Groundbreaking Data Masking Solution To Revolutionize Data Security

How This Consultant Built A Groundbreaking Data Masking Solution To Revolutionize Data Security

Rama Steel Tubes Board Approves ₹500 Crore Further Public Offering; Stock Closes Over 6% In Green

Rama Steel Tubes Board Approves ₹500 Crore Further Public Offering; Stock Closes Over 6% In Green

Global NCAP Crash Test: Kia Carens Achieves 3-Star Safety Rating

Global NCAP Crash Test: Kia Carens Achieves 3-Star Safety Rating